The COVID-19 vaccine made by Cambridge biotech Moderna Inc. will be reviewed on April 30 by the World Health Organization for possible emergency listing, according to a report by Reuters.
The review would be a precursor to the international agency making a final decision on the vaccine between one and four days later. Approval for emergency listing "is a signal to national regulatory authorities on a product's safety and efficacy," Reuters said.
So far, WHO has given emergency listing to the coronavirus vaccines made by Pfizer Inc., Johnson & Johnson and AstraZeneca.
More on this story from Boston Business Journal
Get New England news, weather forecasts and entertainment stories to your inbox. Sign up for NECN newsletters.
Copyright Boston Business Journal
